Issued 2026-09-16 at $42.62 · now $42.62 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, IREN has typically landed between $25.63 and $78.67 — a range of −39.9% to +84.6% from the issuance price $42.62.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,189 overlapping 1 month windows · 2021-11-17 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($42.62) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where IREN has typically landed a month from the 2026-09-16 close of $42.62 — the range is history, not a prediction.
- now $42.62 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $42.43 (-0.4%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $31.77–$53.09
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $25.63–$78.67
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2022-04-14 | −60.3% | −60.3% | +0.0% |
| 2022-10-28 | −57.6% | −57.6% | +0.0% |
| 2022-10-31 | −56.0% | −56.6% | +0.0% |
| 3 best | |||
| 2024-05-14 | +181.3% | +0.0% | +181.3% |
| 2024-05-13 | +179.4% | +0.0% | +179.4% |
| 2023-11-21 | +167.6% | +0.0% | +167.6% |
1,189 overlapping windows · 2021-11-17 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~5 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-16 | Guzowski Christopher | director | Sale | 11,958 @ $36.32 | $434K | −23.4% of holding | +85.4% | +15.0% | 39,168 | Form 4 · filed 288 days after the trade |
| 2025-09-11 | Roberts Daniel John | director | Sale | 1,000,000 @ $33.13 | $33.1M | −6.7% of holding | +82.4% | +25.3% | 13,989,696 | Form 4 · filed same day |
| 2025-09-11 | Roberts William Gregory | director | Sale | 1,000,000 @ $33.13 | $33.1M | −6.7% of holding | +82.4% | +25.3% | 13,989,696 | Form 4 · filed same day |
| 2025-09-04 | Roberts William Gregory | director | Sale | 500,000 @ $23.51 | $11.8M | −100.0% of holding | +89.7% | +36.3% | 0 | Form 4 · filed 1 day after the trade |
| 2025-09-04 | Roberts Daniel John | director | Sale | 500,000 @ $23.51 | $11.8M | −100.0% of holding | +89.7% | +36.3% | 0 | Form 4 · filed 1 day after the trade |
| 2025-09-03 | Roberts Daniel John | director | Sale | 500,000 @ $25.49 | $12.7M | −50.0% of holding | +62.4% | +35.8% | 500,000 | Form 4 · filed 2 days after the trade |
| 2025-09-03 | Roberts William Gregory | director | Sale | 500,000 @ $25.49 | $12.7M | −50.0% of holding | +62.4% | +35.8% | 500,000 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
16 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Lewis Anthony J | officer | Award / grant | 26,968 | 221,483 | Form 4 |
| 2026-07-01 | ALFRED MICHAEL | director | Award / grant | 6,657 | 127,606 | Form 4 |
| 2026-07-01 | Bartholomew David James | director | Award / grant | 8,369 | 153,574 | Form 4 |
| 2026-07-01 | Guzowski Christopher | director | Award / grant | 6,657 | 45,825 | Form 4 |
| 2026-07-01 | Roberts William Gregory | director | Award / grant | 9,099,328 | 23,089,024 | Form 4 |
| 2026-07-01 | Roberts William Gregory | director | Award / grant | 552,197 | 23,641,221 | Form 4 |
| 2026-07-01 | Roberts Daniel John | director | Award / grant | 9,099,328 | 23,089,024 | Form 4 |
| 2026-07-01 | Roberts Daniel John | director | Award / grant | 552,197 | 23,641,221 | Form 4 |
| 2026-07-01 | Parasuraman Sunita | director | Award / grant | 6,657 | 76,691 | Form 4 |
| 2025-07-01 | Nucifora Belinda | officer | Award / grant | 63,910 | 349,798 | Form 4 |
| 2025-07-01 | Bartholomew David James | director | Award / grant | 48,960 | 145,205 | Form 4 |
| 2025-07-01 | Roberts William Gregory | director | Award / grant | 1,793,392 | 14,989,696 | Form 4 |
| 2025-07-01 | Guzowski Christopher | director | Award / grant | 39,168 | 51,126 | Form 4 |
| 2025-07-01 | ALFRED MICHAEL | director | Award / grant | 39,168 | 120,949 | Form 4 |
| 2025-07-01 | Parasuraman Sunita | director | Award / grant | 39,168 | 70,034 | Form 4 |
| 2025-07-01 | Roberts Daniel John | director | Award / grant | 1,793,392 | 14,989,696 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.